In contrast to its putative tumour suppressor status, recent studies assign ING3 an oncogenic role in prostate cancer, based on a higher survival rate of human prostate cancer patients with lower ING3 levels [21]. The gene discussed is ING3; the disease is Familial prostate cancer.